statistiche ricercatore

Continente	#
NA - Nord America	1.434
AS - Asia	679
EU - Europa	662
SA - Sud America	62
Continente sconosciuto - Info sul continente non disponibili	33
AF - Africa	16
Totale	2.886

Nazione	#
US - Stati Uniti d'America	1.389
IT - Italia	212
SG - Singapore	181
CN - Cina	154
GB - Regno Unito	123
HK - Hong Kong	108
VN - Vietnam	75
DE - Germania	63
SE - Svezia	63
BD - Bangladesh	61
BR - Brasile	40
FI - Finlandia	39
FR - Francia	39
RU - Federazione Russa	32
CA - Canada	22
TR - Turchia	18
IN - India	16
UA - Ucraina	15
ID - Indonesia	14
KR - Corea	14
NL - Olanda	14
BE - Belgio	11
ES - Italia	9
MX - Messico	8
AR - Argentina	7
PK - Pakistan	7
AT - Austria	6
BG - Bulgaria	6
PL - Polonia	5
CR - Costa Rica	4
CZ - Repubblica Ceca	4
EG - Egitto	4
IE - Irlanda	4
IQ - Iraq	4
SK - Slovacchia (Repubblica Slovacca)	4
UZ - Uzbekistan	4
VE - Venezuela	4
CL - Cile	3
DK - Danimarca	3
EC - Ecuador	3
JM - Giamaica	3
JP - Giappone	3
KE - Kenya	3
MA - Marocco	3
PH - Filippine	3
CH - Svizzera	2
CO - Colombia	2
EE - Estonia	2
GT - Guatemala	2
IL - Israele	2
MY - Malesia	2
NO - Norvegia	2
PY - Paraguay	2
SA - Arabia Saudita	2
TN - Tunisia	2
TT - Trinidad e Tobago	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AO - Angola	1
AZ - Azerbaigian	1
BB - Barbados	1
BY - Bielorussia	1
CU - Cuba	1
CY - Cipro	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EU - Europa	1
GR - Grecia	1
GY - Guiana	1
IR - Iran	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PS - Palestinian Territory	1
PT - Portogallo	1
RO - Romania	1
Totale	2.854

Nome	#
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients	455
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors	420
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia	361
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis	359
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature	337
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout”	324
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia	286
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience	177
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients	167
Totale	2.886

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	146	0	0	0	8	1	7	11	20	25	16	35	23
2022/2023	207	29	26	14	23	27	12	9	22	19	5	8	13
2023/2024	146	4	3	9	17	21	20	15	32	0	2	8	15
2024/2025	497	16	15	16	23	57	55	45	26	97	16	56	75
2025/2026	957	74	34	65	73	125	48	133	54	103	117	51	80
2026/2027	192	37	57	43	55	0	0	0	0	0	0	0	0
Totale													2.886